High-glycolysis melanoma cells upregulates TGFB1 expression thus increasing the secretion of TGF-β which inhibit mTOR signaling pathway and result in less production of IFN-γ and impaired anti-tumor function. This evidence concerns the gene TGFB1 and melanoma.